Summary

In light of the development of AI tools, AI System providers must also consider data protection. But how are they legally qualified? As a controller, joint controller or processor?The French Data Protection Authority, the Commission Nationale de l’Informatique et des Libertés (CNIL) published a guide about the legal qualification of AI System providers.

Key points to determine the qualification :

· The qualification is on a case by case basis, but some principles can be applied.

· If a Provider decides both the purpose and the means of processing personal data, they are a controller. This may happen if the Provider takes the initiative to develop the AI System and constructs its training dataset by independently selecting data.

· Providers can also be joint controllers. This happens when controllers jointly determine the purpose and means of processing. As an example, in the case of AI Systems, joint controllers feed the training dataset together for a joint purpose.

· A processor processes personal data on behalf of a controller; they act as a service provider. The controller is the one giving instructions about the processing, and the processor carries them out. For example, an AISystem Provider who develops the system as a service provided to one of its customers, following their instructions, is a processor.

·  In practice, two or more academic hospitals, who jointly develop an AI System, pursue a common purpose and decided together on the means of processing, are joint controllers. For example, if they jointly decided to develop a system for the analysis of medical imaging training and chose together the protocol to be followed and the data to exploit, they would be joint controllers.

Link to the Guide :

https://www.cnil.fr/en/determining-legal-qualification-ai-system-providers

Seamus Larroque

CDPO / CPIM / ISO 27005 Certified

Home

Discover our latest articles

View All Blog Posts
June 11, 2026
Events
Data Governance
Data Privacy Enforcement
Health Data Warehouse

Vendor GDPR in Clinical Trials: What the IQVIA CNIL Ruling Changes for Sponsors and Healthtech Companies

On 26 May 2026 the CNIL fined IQVIA Operations France EUR 5 million for failures in its two authorised health data warehouses, LRX and EMR. The decision exposes weaknesses in CRO data protection practice that have direct consequences for every pharmaceutical sponsor relying on a CRO to process patient, prescription or trial data. This article unpacks the four areas of failure, explains why pseudonymisation no longer offers the cover many sponsors assume, and sets out a practical oversight checklist for sponsor data controllers.

February 9, 2026
AI
Biotech & Healthtech
Regulations & Guidelines
Healthcare

EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026

EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.

February 2, 2026
Healthtech
US Privacy Law
USA

Navigating US Regulatory Requirements for AI-Powered Medical Devices: A Comprehensive Guide to FDA, HIPAA, and IRB Compliance

US AI medical device compliance requires navigating FDA, HIPAA, IRBs, and consent waivers strategically.

FAQs

Our frequently questions

No items found.